SREBF2 and breast cancer: In all, our findings suggest that NUCB2/Nesfatin-1 regulates cholesterol synthesis by improving SREBP2 and HMGCR abundance via the mTORC1 pathway, resulting in high metastasis ability in breast cancer both in vitro and in vivo.